Table 2.
Clinical characteristics of the CLL patients (n = 90)
| Characteristic | Frequency (%) |
|---|---|
|
Sex | |
| Male |
70 |
| Female |
30 |
|
Age, y | |
| 40–49 |
7 |
| 50–59 |
7 |
| 60–69 |
38 |
| 70–79 |
39 |
| 80–89 |
10 |
|
Clinical phase | |
| Progressive * |
47 |
| Non-progressive * |
53 |
|
Rai Stage | |
| O |
39 |
| I |
26 |
| II |
7 |
| III |
26 |
| IV |
3 |
|
Treatment | |
| Previously treated ** |
33 |
| Previously untreated *** | 67 |
* For definition, see ref [43].
** Test performed at relapse / progression prior to initiation of salvage therapy.
*** Among 60 untreated patients, 33 were indolent and 27 were progressive/symptomatic but tested prior to first-line therapy.